Inhibrx Biosciences Inc. (INBX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Inhibrx Biosciences Inc.

    NASDAQ: INBX · Real-Time Price · USD
    28.18
    0.46 (1.66%)
    At close: Sep 05, 2025, 3:59 PM
    28.18
    0.00%
    After-hours: Sep 05, 2025, 04:33 PM EDT

    Inhibrx Biosciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 200K 1.8M 2.19M 7.13M
    Cost of Revenue
    		 2.29M 1.19M 110.19M 2.69M
    Gross Profit
    		 -2.08M 609K -107.99M 4.44M
    Operating Income
    		 -331.45M -219.22M -129.12M -76.56M
    Interest Income
    		 10.94M 11.92M 16.11M 5.22M
    Pretax Income
    		 1.69B -239.72M -145.22M -81.77M
    Net Income
    		 1.69B -241.36M -145.23M -81.77M
    Selling & General & Admin
    		 127.91M 29.38M 21.12M 12.36M
    Research & Development
    		 203.74M 190.65M 110.19M 71.44M
    Other Expenses
    		 -2.29M -199K -110.19M -71.45M
    Operating Expenses
    		 329.36M 219.83M 21.12M 12.34M
    Interest Expense
    		 13.49M 31.84M 16.11M 5.22M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 331.65M 221.02M 131.29M 83.69M
    Income Tax Expense
    		 2K 3K 3K 2K
    Shares Outstanding (Basic)
    		 14.48M 47.13M 40.11M 38.01M
    Shares Outstanding (Diluted)
    		 14.48M 47.13M 40.11M 38.01M
    EPS (Basic)
    		 116.58 -5.12 -3.62 -2.15
    EPS (Diluted)
    		 116.58 -5.12 -3.62 -2.15
    EBITDA
    		 1.7B -206.69M -125.82M -75.37M
    EBIT
    		 1.7B -207.88M -127.04M -76.56M
    Depreciation & Amortization
    		 2.29M 1.19M 1.23M 1.2M

    Add to Watchlist